Mercator Medical S.A. (FRA:MM2)

Mercator Medical Statistics

Total Valuation

FRA:MM2 has a market cap or net worth of EUR 93.10 million. The enterprise value is 66.81 million.

Market Cap	93.10M
Enterprise Value	66.81M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.94M
Shares Outstanding	n/a
Shares Change (YoY)	-0.95%
Shares Change (QoQ)	+17.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.62%
Float	4.24M

Valuation Ratios

The trailing PE ratio is 4.06.

PE Ratio	4.06
Forward PE	n/a
PS Ratio	0.69
PB Ratio	0.45
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.27, with an EV/FCF ratio of -2.85.

EV / Earnings	2.92
EV / Sales	0.49
EV / EBITDA	50.27
EV / EBIT	n/a
EV / FCF	-2.85

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.03.

Current Ratio	6.95
Quick Ratio	2.89
Debt / Equity	0.03
Debt / EBITDA	4.18
Debt / FCF	-0.24
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.79% and return on invested capital (ROIC) is -1.16%.

Return on Equity (ROE)	10.79%
Return on Assets (ROA)	-1.04%
Return on Invested Capital (ROIC)	-1.16%
Return on Capital Employed (ROCE)	-1.85%
Revenue Per Employee	142,779
Profits Per Employee	24,115
Employee Count	950
Asset Turnover	0.57
Inventory Turnover	2.06

Taxes

Income Tax	-5.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.41%
50-Day Moving Average	9.48
200-Day Moving Average	10.24
Relative Strength Index (RSI)	30.56
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MM2 had revenue of EUR 135.64 million and earned 22.91 million in profits. Earnings per share was 2.45.

Revenue	135.64M
Gross Profit	37.49M
Operating Income	-4.01M
Pretax Income	17.80M
Net Income	22.91M
EBITDA	1.32M
EBIT	-4.01M
Earnings Per Share (EPS)	2.45

Balance Sheet

The company has 30.86 million in cash and 5.53 million in debt, giving a net cash position of 25.33 million.

Cash & Cash Equivalents	30.86M
Total Debt	5.53M
Net Cash	25.33M
Net Cash Per Share	n/a
Equity (Book Value)	208.59M
Book Value Per Share	21.70
Working Capital	111.29M

Cash Flow

In the last 12 months, operating cash flow was -13.97 million and capital expenditures -9.44 million, giving a free cash flow of -23.41 million.

Operating Cash Flow	-13.97M
Capital Expenditures	-9.44M
Free Cash Flow	-23.41M
FCF Per Share	n/a

Margins

Gross margin is 27.64%, with operating and profit margins of -2.96% and 16.89%.

Gross Margin	27.64%
Operating Margin	-2.96%
Pretax Margin	13.12%
Profit Margin	16.89%
EBITDA Margin	0.97%
EBIT Margin	-2.96%
FCF Margin	n/a

Dividends & Yields

FRA:MM2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.95%
Shareholder Yield	0.95%
Earnings Yield	24.61%
FCF Yield	-25.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3